Showing results (251-260 of 276) with videos related to
Sort By:
Pageof 28
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 22, 2023
Detection of Second Primary Lymphoma in Late Diffuse Large B-cell Lymphoma RecurrencesMadeleine R Berendsen, Diede A G van Bladel, Eva Hesius, et al.Hemasphere|April 20, 2026
Biological and clinical characteristics of <i>ETV6</i>::<i>RUNX1</i>-like ALLMarketa Zaliova, Dagmar Schinnerl, Judith M Boer, et al.Leukemia|February 15, 2013
High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantationG M Marshall, L Dalla Pozza, R Sutton, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 5, 2021
<sup>89</sup>Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancerI C Kok, J S Hooiveld, P P van de Donk, et al.Brain : a Journal of Neurology|March 25, 2024
Connecting dementia risk loci to the CSF proteome identifies pathophysiological leads for dementiaLianne M Reus, Iris E Jansen, Betty M Tijms, et al.Leukemia|July 24, 2015
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative studyJ M Boer, A van der Veer, D Rizopoulos, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 5, 2021
A Validated Risk Prediction Model for Bone Fragility in Children With Acute Lymphoblastic LeukemiaEmma J Verwaaijen, Jinhui Ma, Hester A de Groot-Kruseman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2023
Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood <i>KMT2A</i>-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study GroupRomy E van Weelderen, Kim Klein, Christine J Harrison, et al.Nature Medicine|December 5, 2022
Whole-body CD8<sup>+</sup> T cell visualization before and during cancer immunotherapy: a phase 1/2 trialLaura Kist de Ruijter, Pim P van de Donk, Jahlisa S Hooiveld-Noeken, et al.Nature|October 2, 2019
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugsD L van der Velden, L R Hoes, H van der Wijngaart, et al.Pageof 28